Note: Ingredients listed on restricted chemical lists
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
1 - 1.5
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
(0.0015 ≤ C ≤ 100) Skin Sens. 1A; H317
General Information
Version
2.0 EN
Revision date
2024-06-27
Product name
Gentian Calprotectin Control Kit
1.2.1 Relevant identified uses
Industrial/Professional use spec
Emergency telephone
+61 2 9845 3969, +372 7943 794, +358 800 147 111, +358 9 471 977, 0800 147 111, 09 471 977, +353 1 809 2566, +353 1 809 2166, +356 2545 6508, +31 88 755 8000, +386 522 52 83, +44 191 2606182, +44 191 2606180, 0344 892 0111
Icons in SDS
Company Information
company name
Gentian AS
e-mail address of the competent person responsible for the Safety Data Sheet
info@gentian.no
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Hazard statements
see section 16 : H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Contains
2-methylisothiazol-3(2H)-one
Precautionary statements
P280 - Wear eye protection, protective gloves, protective clothing. P302+P352 - IF ON SKIN: Wash with plenty of soap and water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
